デフォルト表紙
市場調査レポート
商品コード
1439281

血液・輸液加温医療機器の世界市場:洞察、競合情勢、市場予測:2030年

Blood and Fluid Warming Medical Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血液・輸液加温医療機器の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血液・輸液加温医療機器の市場規模は、2024年から2030年までの予測期間中に6.49%のCAGRで拡大すると予測されています。血液・輸液加温医療機器は、低体温症例の増加、高齢者・乳幼児人口の負担増、入院・手術・外傷症例の急増、輸血を必要とする慢性疾患の症例増加など、さまざまな要因によって、世界的にプラス成長を遂げています。

血液・輸液加温医療機器の主な促進要因の1つは、心血管、がん、泌尿器、神経などの慢性疾患の有病率の増加による手術・外傷ケースの増加です。

例えば、GLOBOCANデータ2020によると、膀胱がんの負担は2020年に1,930万件に増加し、膀胱がんは世界で10番目に頻度の高いがんです。上記の出典によると、2020年には世界で573,278人が膀胱がんと診断されました。さらに、同じ情報源によれば、2020年の乳がんの罹患率は世界全体で47.6%と報告されています。同じように、がんの有病率は日々増加しており、今後数年間も同様に増加すると予想されています。がんは通常、腫瘍を体外に摘出する外科手術によって治療されます。通常、外科手術のほとんどは輸血と輸液を必要とします。その際、血液や輸液を温める器具を使って血液を温めることがあります。したがって、さまざまなタイプのがんの有病率の増加は、外科手術の数を増加させ、それによって輸血中に必要な血液および流体加温装置の需要を増加させます。

血液・体液加温装置の需要を押し上げるもう一つの要因は、世界中で低体温症が増加していることです。低体温症の主な原因因子は、神経機能障害、薬物中毒、環境暴露です。米国疾病予防管理センター(CDC)によると、2022年には米国で毎年1,000人近くが低体温症により死亡しています。この死亡率は、血液や体液を温める装置を用いて適切な体温や血液の温度を確保することで減らすことができます。したがって、低体温症患者の増加は、今後数年間で血液・体液加温装置の需要を増加させるとみられています。

当レポートでは、世界の血液・輸液加温医療機器市場について調査し、市場の概要とともに、システムタイプ別、ポータビリティ別、用途別、ンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 血液・輸液加温医療機器レポートのイントロダクション

第2章 血液・輸液加温医療機器のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 血液・輸液加温医療機器の主な要因分析

  • 血液・輸液加温医療機器市場の促進要因
  • 血液・輸液加温医療機器市場の抑制要因と課題
  • 血液・輸液加温医療機器市場の機会

第5章 血液・輸液加温医療機器におけるポーターのファイブフォース分析

第6章 血液・輸液加温医療機器に対するCOVID-19の影響分析

第7章 血液・輸液加温医療機器の市場概要

  • システムタイプ別
  • ポータビリティ別
  • 用途別
  • エンドユーザー別
  • 地域別

第8章 血液・輸液加温医療機器の世界企業シェア分析-主要3~5社

第9章 血液・輸液加温医療機器の企業と製品プロファイル

  • General Electric Company
  • ICU Medical, Inc.
  • BD
  • Boston Scientific Corporation
  • 3M
  • Barkey
  • SINO MDT
  • EMIT CORPORATION
  • Weiss Technik North America, Inc.
  • Stihler Electronic GmbH
  • Biegler GmbH
  • Belmont Medical Technologies
  • Stryker
  • GENTHERM.
  • Vyaire Medical, Inc
  • The Surgical Company.
  • Life Warmer
  • MEQU
  • Blue Neem Medical Devices Pvt Ltd
  • ACE Medical Devices Pvt. Ltd

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Blood and Fluid Warming Medical Devices in Global (2021-2030)
  • Table 4: Blood and Fluid Warming Medical Devices in Global by System Type (2021-2030)
  • Table 5: Blood and Fluid Warming Medical Devices in Global by Portability (2021-2030)
  • Table 6: Blood and Fluid Warming Medical Devices in Global by Application(2021-2030)
  • Table 7: Blood and Fluid Warming Medical Devices in Global by End User (2021-2030)
  • Table 8: Blood and Fluid Warming Medical Devices in Global by Geography (2021-2030)
  • Table 9: Blood and Fluid Warming Medical Devices in North America (2021-2030)
  • Table 10: Blood and Fluid Warming Medical Devices in North America by Country (2021-2030)
  • Table 11: Blood and Fluid Warming Medical Devices in the US (2021-2030)
  • Table 12: Blood and Fluid Warming Medical Devices in Canada (2021-2030)
  • Table 13: Blood and Fluid Warming Medical Devices in Mexico (2021-2030)
  • Table 14: Blood and Fluid Warming Medical Devices in Europe (2021-2030)
  • Table 15: Blood and Fluid Warming Medical Devices in Europe by Country (2021-2030)
  • Table 16: Blood and Fluid Warming Medical Devices in France (2021-2030)
  • Table 17: Blood and Fluid Warming Medical Devices in Germany (2021-2030)
  • Table 18: Blood and Fluid Warming Medical Devices in the United Kingdom (2021-2030)
  • Table 19: Blood and Fluid Warming Medical Devices in Italy (2021-2030)
  • Table 20: Blood and Fluid Warming Medical Devices in Spain (2021-2030)
  • Table 21: Blood and Fluid Warming Medical Devices in Russia (2021-2030)
  • Table 22: Blood and Fluid Warming Medical Devices in Rest of Europe (2021-2030)
  • Table 23: Blood and Fluid Warming Medical Devices in APAC (2021-2030)
  • Table 24: Blood and Fluid Warming Medical Devices in APAC by Country (2021-2030)
  • Table 25: Blood and Fluid Warming Medical Devices in China (2021-2030)
  • Table 26: Blood and Fluid Warming Medical Devices in Japan (2021-2030)
  • Table 27: Blood and Fluid Warming Medical Devices in India (2021-2030)
  • Table 28: Blood and Fluid Warming Medical Devices in Australia (2021-2030)
  • Table 29: Blood and Fluid Warming Medical Devices in South Korea (2021-2030)
  • Table 30: Blood and Fluid Warming Medical Devices in Rest of APAC (2021-2030)
  • Table 31: Blood and Fluid Warming Medical Devices in Rest of World (2021-2030)
  • Table 32: Blood and Fluid Warming Medical Devices in RoW by Region (2021-2030)
  • Table 33: Blood and Fluid Warming Medical Devices in Middle East (2021-2030)
  • Table 34: Blood and Fluid Warming Medical Devices in Africa (2021-2030)
  • Table 35: Blood and Fluid Warming Medical Devices in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Blood and Fluid Warming Medical Devices in Global (2021-2030)
  • Figure 4: Blood and Fluid Warming Medical Devices in Global by System Type (2021-2030)
  • Figure 5: Blood and Fluid Warming Medical Devices in Global by Portability (2021-2030)
  • Figure 6: Blood and Fluid Warming Medical Devices in Global by Application(2021-2030)
  • Figure 7: Blood and Fluid Warming Medical Devices in Global by End User (2021-2030)
  • Figure 8: Blood and Fluid Warming Medical Devices in Global by Geography (2021-2030)
  • Figure 9: Blood and Fluid Warming Medical Devices in North America (2021-2030)
  • Figure 10: Blood and Fluid Warming Medical Devices in North America by Country (2021-2030)
  • Figure 11: Blood and Fluid Warming Medical Devices in the US (2021-2030)
  • Figure 12: Blood and Fluid Warming Medical Devices in Canada (2021-2030)
  • Figure 13: Blood and Fluid Warming Medical Devices in Mexico (2021-2030)
  • Figure 14: Blood and Fluid Warming Medical Devices in Europe (2021-2030)
  • Figure 15: Blood and Fluid Warming Medical Devices in Europe by Country (2021-2030)
  • Figure 16: Blood and Fluid Warming Medical Devices in France (2021-2030)
  • Figure 17: Blood and Fluid Warming Medical Devices in Germany (2021-2030)
  • Figure 18: Blood and Fluid Warming Medical Devices in the United Kingdom (2021-2030)
  • Figure 19: Blood and Fluid Warming Medical Devices in Italy (2021-2030)
  • Figure 20: Blood and Fluid Warming Medical Devices in Spain (2021-2030)
  • Figure 21: Blood and Fluid Warming Medical Devices in Russia (2021-2030)
  • Figure 22: Blood and Fluid Warming Medical Devices in Rest of Europe (2021-2030)
  • Figure 23: Blood and Fluid Warming Medical Devices in APAC (2021-2030)
  • Figure 24: Blood and Fluid Warming Medical Devices in APAC by Country (2021-2030)
  • Figure 25: Blood and Fluid Warming Medical Devices in China (2021-2030)
  • Figure 26: Blood and Fluid Warming Medical Devices in Japan (2021-2030)
  • Figure 27: Blood and Fluid Warming Medical Devices in India (2021-2030)
  • Figure 28: Blood and Fluid Warming Medical Devices in Australia (2021-2030)
  • Figure 29: Blood and Fluid Warming Medical Devices in South Korea (2021-2030)
  • Figure 30: Blood and Fluid Warming Medical Devices in Rest of APAC (2021-2030)
  • Figure 31: Blood and Fluid Warming Medical Devices in Rest of World (2021-2030)
  • Figure 32: Blood and Fluid Warming Medical Devices in RoW by Region (2021-2030)
  • Figure 33: Blood and Fluid Warming Medical Devices in Middle East (2021-2030)
  • Figure 34: Blood and Fluid Warming Medical Devices in Africa (2021-2030)
  • Figure 35: Blood and Fluid Warming Medical Devices in South America (2021-2030)
  • Figure 36: Market Drivers
  • Figure 37: Market Barriers
  • Figure 38: Marker Opportunities
  • Figure 39: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0071

Blood and Fluid Warming Medical Devices By System Type (Intravenous Warming System, Patient Warming System, And Surface Warming System), By Portability (Portable And Non-Portable), By Application (New Born Care, Pre-Operative Care, Acute Care, Homecare, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing number of hypothermia cases and the increasing number of geriatric and infant population

The global blood and fluid warming medical devices is expected to grow at a CAGR of 6.49% during the forecast period from 2024 to 2030. The blood and fluid warming medical devices is witnessing positive growth owing to various factors such as rising cases of hypothermia, the escalating burden of geriatric and infant's population, surging number of hospital admissions, surgeries and trauma cases, and the rising cases of chronic diseases requiring blood transfusion across the globe. Therefore, the market for blood and fluid warming devices is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Blood and Fluid Warming Medical Devices Dynamics:

One of the main drivers of the blood and fluid warming medical devices is the increasing figure of surgeries & trauma cases due to the increasing prevalence of chronic disorders such as cardiovascular, cancers, urological, neurological, among others.

For instance, as per the GLOBOCAN data 2020, the bladder cancer burden has increased to 19.3 million cases in the year 2020 and bladder cancer is the tenth most frequent cancer worldwide. According to the source mentioned above, 573,278 people worldwide were diagnosed with bladder cancer in the year 2020. Moreover, as per the same source, the incidence rate of breast cancer was reported to be 47.6%, globally, in the year 2020. In the same way the prevalence of cancers are increasing day by day and is expected to increase in the similar manner in the upcoming years. Cancer are usually treated with some surgical procedures where the tumour is removed from the body. Usually most of the surgical procedures require blood and fluid transfusion. During this process, blood is sometime warmed using the blood and fluid warming devices. Thus, the increasing prevalence of different type cancers will increase the number of surgical procedures, thereby increasing the demand of blood and fluid warming devices, required during blood transfusion.

Another factor which will drive the demand of blood and fluid warming devices is the increasing cases of hypothermia across the globe. The major causative factor for hypothermia are nerve function dysfunction, drug intoxication, and environmental exposure. According to the Centers for Disease Prevention and Control (CDC), 2022, nearly 1,000 deaths occur every year in the United States due to hypothermia. The mortality rate can be reduced by ensuring a proper body and blood temperature using blood and fluid warming devices. Thus, the increasing cases of hypothermia will increase the demand of blood and fluid warming devices in the forthcoming years.

Therefore, the factors stated above collectively will drive the overall blood and fluid warming medical devices during the forecast period from 2024-2030.

However, the less awareness of blood and fluid warming devices, stringent regulatory approval process and others, can hamper the global blood and fluid warming medical devices growth.

The COVID-19 epidemic has significantly impacted the blood and fluid warming devices market. The nationwide lockdown in almost every country-restricted people's movement & hospital visits, halted supply chains & logistics, hampered the manufacturing process, resulting in a product shortage in the market, and elective surgeries and blood transfusion process were also halted and were not on priority because COVID-19 patients were given priority in terms of treatment. However, the hospital admissions of the patients suffering from COVID-19 was increased. High fever and shivering was one of the basic symptoms of patients who may be suffering from COVID-19. As a result, use of warm blankets and sterile fluids increased due to the increasing number of patients in hospitals and clinics, this is in turn can be expected to propel industry growth. Moreover, with the masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, manufacturing units, increase in elective surgeries for the treatment of chronic diseases and trauma, and the increasing demand of warming devices for COVID-19 patients, the blood and fluid warming devices demand increased and is expected to further grow during the forecast period.

Blood and Fluid Warming Medical Devices Segment Analysis:

Blood and Fluid Warming Medical Devices By System Type (Intravenous Warming System, Patient Warming System, and Surface Warming System), Portability (Portable and Non-Portable), Application (New Born Care, Pre-Operative Care, Acute Care, Homecare, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the system type segment of the blood and fluid warming medical devices, the surface warming system market is expected to have a significant revenue share in the year 2023. This was primarily owing to the increasing cases of surgeries and trauma or accidents across the globe. Surface warming systems are usually used during the perioperative process, thereby the increasing number of surgeries due to some trauma or accidents will be responsible for the growth of the device.

According to the Transport Canada's National Collision Database (NCDB) 2022, nearly 7,868 serious or severe injuries were reported due to some accidents in the year 2020, in Canada. As per the same source, the number of total injuries were reported to be 101,572 in 2020, in Canada.

Moreover, according to the Transport Research Wing 2020, a total number of 3,66,138 road accidents have been reported by States and Union Territories (UTs) during the calendar year 2020, claiming 1,31,714 lives and causing serious injuries to 3,48,279 people. These injuries might require a surgical procedure for its treatment, ultimately increasing the number of surgical procedures. The increase in surgical procedures will increase the demand of surface warming system, a blood and fluid warming device used by surgeons during the perioperative process.

Moreover, due to the interplay of all the factors mentioned above, this can result in the rising demand for surface warming blood and fluid warming devices, which in turn would provide a conducive growth environment for overall blood and fluid warming devices during the market forecast 2024-2030.

North America is expected to dominate the overall Blood and Fluid Warming Medical Devices:

Among all the regions, North America is expected to dominate the global blood and fluid warming medical devices in the year 2023 and is expected to do the same during the forecast period of 2024-2030. Factors such as the increasing number of trauma & surgery in the region, rising prevalence of chronic disorders & cancers, and the rise in the regulatory approvals for blood and fluid warming devices will increase the demand for blood and fluid warming devices in the North America market.

According to the American Cancer Society (2023), in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. The treatment and management of cancers might require a surgical procedure in which the tumor is removed. Surgeries always require blood transfusion and prior to the blood transfusion the temperature of the blood should be optimum so as to avoid any complications. In order to achieve, an ideal blood temperature a blood and fluid warming devices are used, thereby increasing its demand in the market. Thus, the increasing prevalence of cancer will increase the number of surgery and blood transfusion, therefore increasing the demand of blood and transfusion devices used to achieve proper blood temperature during the transfusion process.

Additionally, the surge in number of surgical procedure owing to a rise in the number of trauma or accidents cases in the region will spur the market of blood and fluid warming devices. As per the data concluded by US Bureau of Labor Statistics 2022, there were approximately 4,764 fatal work injuries recorded in the United States in 2020. The work injuries will require some short of surgical procedure, which will require blood transfusion and blood and fluid warming devices.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the blood and fluid warming medical devices.

Blood and Fluid Warming Medical Devices Key Players:

Some of the key market players operating in the blood and fluid warming medical devices include General Electric Company, ICU Medical, Inc., BD, Boston Scientific Corporation, 3M, Barkey, SINO MDT, EMIT CORPORATION, Weiss Technik North America, Inc., Stihler Electronic GmbH, Biegler GmbH, Belmont Medical Technologies, Stryker, GENTHERM., Vyaire Medical, Inc, The Surgical Company., Life Warmer, MEQU, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd, and others.

Recent Developmental Activities in the Blood and Fluid Warming Medical Devices:

In April 2022, MEQU, Danish medtech company, had launched an in-hospital solution, °M Station, for its blood and IV fluid warming device, °M Warmer System. M Warmer System is a portable blood and IV fluid warming device that is adopted in the pre-hospital and military sectors.

In January 2019, Life Warmer, Inc., received 510 (k) approval for the marketing of the Quantum Blood and IV Fluid Infusion Warmer.

Key Takeaways from the Blood and Fluid Warming Medical Devices Report Study

  • Market size analysis for current blood and fluid warming medical devices (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the blood and fluid warming medical devices
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the global blood and fluid warming medical devices
  • Various opportunities are available for the other competitor in the blood and fluid warming medical devices space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current blood and fluid warming medical devices scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for blood and fluid warming medical devices growth in the coming future?

Target Audience who can be benefited from this Blood and Fluid Warming Medical Devices Report Study

  • Blood and fluid warming medical devices providers
  • Research organizations and consulting companies
  • Blood and fluid warming medical devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in blood and fluid warming medical devices
  • Various end-users who want to know more about the blood and fluid warming medical devices and the latest technological developments in the blood and fluid warming medical devices

Frequently Asked Questions for Blood And Fluid Warming Medical Devices:

1. What are Blood and Fluid Warming Medical Devices?

A blood warmer, is a medical devices used to warm blood or other fluids, minimizing the risk of hypothermia. On the other hand, a fluid warming device, is a medical devices used in healthcare facilities for warming fluids, crystalloid, colloid, or blood product, prior to being administered to body temperature levels in order to prevent hypothermia in physically traumatized or surgical patients.

2. What is the market for Global Blood and Fluid Warming Medical Devices?

The global blood and fluid warming medical devices is expected to grow at a CAGR of 6.49% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Blood and Fluid Warming Medical Devices?

The blood and fluid warming medical devices is witnessing a positive market growth owing to the factors such as the rising cases of hypothermia, the escalating burden of geriatric and infants population, surging number of hospital admissions, surgeries and trauma cases, and the rising cases of chronic diseases requiring blood transfusion, and the rise in the regulatory approvals for blood and fluid warming devices.

4. Who are the key players operating in the Blood and Fluid Warming Medical Devices?

Some of the key market players operating in the blood and fluid warming medical devices include General Electric Company, ICU Medical, Inc., BD, Boston Scientific Corporation, 3M, Barkey, SINO MDT, EMIT CORPORATION, Weiss Technik North America, Inc., Stihler Electronic GmbH, Biegler GmbH, Belmont Medical Technologies, Stryker, GENTHERM., Vyaire Medical, Inc, The Surgical Company., Life Warmer, MEQU, Blue Neem Medical Devices Pvt Ltd, ACE Medical Devices Pvt. Ltd, and others

5. Which region has the highest share in Blood and Fluid Warming Medical Devices?

North America is expected to dominate the global blood and fluid warming medical devices. Factors contributing to the growth are the increasing prevalence of surgeries, hospitals admissions, and trauma cases, the rising number of chronic disorders, and the rise in the regulatory approvals for blood and fluid warming medical devices, which are contributing to the growth of the blood and fluid warming medical devices in the North America region.

Table of Contents

1. Blood and Fluid Warming Medical Devices Report Introduction

2. Blood and Fluid Warming Medical Devices Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The US
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Blood and Fluid Warming Medical Devices Key Factors Analysis

  • 4.1. Blood and Fluid Warming Medical Devices Drivers
    • 4.1.1. Rising Cases of Hypothermia
    • 4.1.2. The Increasing Number of Geriatric and Infants Population
    • 4.1.3. Surging Number of Hospital Admissions, Surgeries, and Trauma Cases
    • 4.1.4. The Rising Cases of Chronic Diseases Requiring Blood Transfusion
  • 4.2. Blood and Fluid Warming Medical Devices Restraints And Challenges
    • 4.2.1. Less Awareness of Blood and Fluid Warming Devices
    • 4.2.2. Stringent Regulatory Approval Process
  • 4.3. Blood and Fluid Warming Medical Devices Opportunities
    • 4.3.1. The Increasing Research and Development Activities for Advanced Devices
    • 4.3.2. Increasing Demand of Devices in Emerging Countries

5. Blood and Fluid Warming Medical Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Blood and Fluid Warming Medical Devices

7. Blood and Fluid Warming Medical Devices Layout

  • 7.1. By System Type
    • 7.1.1. Intravenous Warming System
    • 7.1.2. Patient Warming System
    • 7.1.3. Surface Warming System
  • 7.2. By Portability
    • 7.2.1. Portable
    • 7.2.2. Non-portable
  • 7.3. By Application
    • 7.3.1. New Born Care
    • 7.3.2. Pre-operative Care
    • 7.3.3. Acute Care
    • 7.3.4. Homecare
    • 7.3.5. Others
  • 7.4. By End User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.1.2. Canada Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.1.3. Mexico Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.2.2. Germany Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.2.3. United Kingdom Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.2.4. Italy Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.2.5. Spain Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.2.6. Russia Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.2.7. Rest of Europe Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.3.2. Japan Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.3.3. India Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.3.4. Australia Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.3.5. South Korea Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.3.6. Rest of Asia Pacific Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.4.2. Africa Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)
      • 7.5.4.3. South America Blood and Fluid Warming Medical Devices Market Size in USD Million (2021-2030)

8. Blood and Fluid Warming Medical Devices Global Company Share Analysis - Key 3-5 Companies

9. Blood and Fluid Warming Medical Devices Company and Product Profiles

  • 9.1. General Electric Company
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. ICU Medical, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. BD
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Boston Scientific Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. 3M
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Barkey
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. SINO MDT
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. EMIT CORPORATION
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Weiss Technik North America, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Stihler Electronic GmbH
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Biegler GmbH
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Belmont Medical Technologies
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Stryker
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. GENTHERM.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Vyaire Medical, Inc
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. The Surgical Company.
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Life Warmer
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. MEQU
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Blue Neem Medical Devices Pvt Ltd
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. ACE Medical Devices Pvt. Ltd
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us